Project IMPACT Immunizations (IMProving America's Communities Together)

July 11, 2016 updated by: American Pharmacists Association Foundation
The primary objective of this study is to evaluate how implementing an innovative care model that provides the pharmacist access to a patient's vaccine history at the point-of-care impacts the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This is a multi-site, observational study investigating the impact of implementing an innovative care model on the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations. The innovative care model enables the pharmacist to utilize a bi-directional IIS to assess patients' vaccination histories, identify unmet vaccination needs, and document the care provided. Data will be collected in the bi-directional IIS. Aggregate de-identified data will be reported to the researchers at the midpoint and conclusion of the study. The project duration has been established to allow sufficient time for each pharmacy to implement the innovative care model and monitor each pharmacy for a 6-month study period. The American Pharmacists Association (APhA) Foundation has an a priori intent to publish the project results.

Study Type

Observational

Enrollment (Actual)

1080

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Washington
      • Belfair, Washington, United States, 98528
        • Quality Food Centers #101
      • Cheney, Washington, United States, 99004
        • Cheney-Owl Pharmacy
      • Eatonville, Washington, United States, 98328
        • Kirk's Pharmacy
      • Edmonds, Washington, United States, 98020
        • Quality Food Centers #851
      • Lopez Island, Washington, United States, 98261
        • Lopez Island Pharmacy
      • Seattle, Washington, United States, 98104
        • Kelley-Ross Pharmacy
      • Spokane, Washington, United States, 99207
        • ReliantRx
      • Yakima, Washington, United States, 98902
        • Tieton Village Drug

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients receiving an influenza vaccine

Description

Inclusion Criteria:

  • Individuals eligible to be enrolled in the study include any person at least 18 years of age receiving an influenza vaccination from a participating pharmacy site.

Exclusion Criteria:

  • n/a

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Receiving Influenza Vaccine
Patients who receive an influenza vaccine at a participating pharmacy site will be eligible to: a) receive a vaccination forecast review, b) be evaluated for unmet vaccination needs, c) receive patient education, and d) have vaccination needs met.
Biological: Vaccine administration by a pharmacist
Administration, number and types, of vaccine(s) by a pharmacist
Behavioral: Unmet vaccination needs identified and met
Identification of unmet vaccination needs and having those needs met
Behavioral: Vaccination forecast review and patient education
Pharmacist review of the vaccination forecast and patient education on his/her vaccine needs

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number and types of vaccines administered
Time Frame: Change from baseline rates at 6 months
Change from baseline rates at 6 months
Number of unmet vaccination needs identified and met
Time Frame: through study completion, an average of 6 months
through study completion, an average of 6 months
Number of times the pharmacist reviewed the vaccination forecast and educated the patient on his/her vaccine needs
Time Frame: through study completion, an average of 6 months
through study completion, an average of 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

American Pharmacists Association Foundation

Investigators

  • Principal Investigator: Benjamin M Bluml, BPharm, American Pharmacists Association

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2015

Primary Completion (Actual)

April 1, 2016

Study Completion (Actual)

July 1, 2016

Study Registration Dates

First Submitted

October 20, 2015

First Submitted That Met QC Criteria

October 21, 2015

First Posted (Estimate)

October 22, 2015

Study Record Updates

Last Update Posted (Estimate)

July 12, 2016

Last Update Submitted That Met QC Criteria

July 11, 2016

Last Verified

July 1, 2016

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 015

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Influenza

Clinical Trials on Vaccine administration by a pharmacist

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe